2023-11-0811:29
Zennova Pharma Group’s China facility is in production recently. Its 350,000 SQF state-of- the-art cGMP facility will support US & global markets for various of Rx products.
Prev:Zennova Pharmaceuticals (Chengdu) Co., Ltd. Successfully Passes Sichuan MPA's On-site Pharmaceutical Production License GMP Inspection
Next:Zennova Pharmaceutical partners with Innogenix Pharmaceuticals